UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Consumer healthcare giant born out of GSK-Pfizer tie-up
Multinational drugmakers GSK and Pfizer said they would merge consumer heal...
by Nam Doo-hyun
|
2018-12-20 14:40
라인
Local firms rush to develop blinding disease treatments
The macular degeneration treatment market is heating up with local drugmake...
by Nam Doo-hyun
|
2018-12-20 14:37
라인
Astellas Korea rebuked for arbitrarily modifying trials
Astellas Korea received administrative punishment for changing details of t...
by Lee Hye-seon
|
2018-12-20 11:05
라인
Daewoong to export BTX product to 3 countries
Daewoong Pharmaceutical said Thursday that it has signed an export agreemen...
by Lee Han-soo
|
2018-12-20 10:40
라인
Hanmi’s lung cancer drug fails to win breakthrough therapy designation
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Thursday that Poziotini...
by Lee Han-soo
|
2018-12-20 10:40
라인
Bridge Bio, Daewoong to co-develop ulcerative colitis drug candidate
Bridge Biotherapeutics said Wednesday that the company has signed a license...
by Lee Han-soo
|
2018-12-20 10:39
라인
Beta-cell preservation key for Korean diabetes patients
An expert has claimed that beta cell preservation is essential for the mana...
by Lee Han-soo
|
2018-12-19 15:55
라인
Drugmaker booked for bribing doctors with propofol discounts
The police caught a pharmaceutical firm bribing physicians by selling anest...
by Lee Hye-seon
|
2018-12-19 14:12
라인
Handok to test new insomnia drug in phase-3 study
Handok said it would conduct a global phase-3 clinical trial to test Nemore...
by Lee Hye-seon
|
2018-12-19 11:44
라인
Bridge Biotherapeutics announces FDA Clearance for idiopathic pulmonary fibrosis treatment
Bridge Biotherapeutics said Monday that the U.S. Food and Drug Administrati...
by Lee Han-soo
|
2018-12-19 10:25
라인
Korea’s botulinum toxin exports rebound in November
Exports of botulinum toxin products, which had declined for several months,...
by Nam Doo-hyun
|
2018-12-18 15:51
라인
Will healthcare meetings restore investor confidence in pharmaceuticals?
Industry officials are looking what kind of positive issues will boost inve...
by Nam Doo-hyun
|
2018-12-17 15:44
라인
Shinpoong’s drug becomes first-line malaria treatment in Côte d'Ivoire
Korean drugmaker Shinpoong Pharm said Côte d'Ivoire listed the co...
by Park Gi-taek
|
2018-12-17 14:20
라인
Sanofi launches five P3 clinical trials for Hanmi’s diabetic drug
Hanmi Pharmaceutical said Friday that Sanofi, its global partner for efpegl...
by Lee Han-soo
|
2018-12-14 15:17
라인
New hepatitis C drugs compete in shrinking market
Despite the shrinking size of the hepatitis C treatment market with more pa...
by Nam Doo-hyun
|
2018-12-14 15:14
라인
Yuyu unveils new osteoporosis treatment
Yuyu Pharmaceutical said Thursday that it has launched Bazestar, a compound...
by Lee Han-soo
|
2018-12-13 11:50
라인
SK, Sanofi begins P1 clinical trials for next-gen pneumococcal vaccine
SK Bioscience and Sanofi have started to conduct the U.S. phase 1 clinical ...
by Lee Han-soo
|
2018-12-12 17:22
라인
Dong-A ST, Eugene Bell Foundation to supply tuberculosis drug to NK
Dong-A ST said Wednesday that it has signed sponsorship agreement with Euge...
by Lee Han-soo
|
2018-12-12 17:20
라인
Handok to test diabetes-yslipidemia combo
Handok said it has started developing a combination drug, mixing type-2 dia...
by Lee Hye-seon
|
2018-12-12 16:18
라인
CJ Healthcare, DGMIF to co-develop new drug
CJ Healthcare said Wednesday that it has signed a memorandum of understandi...
by Lee Han-soo
|
2018-12-12 13:56
-
이전
61
62
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top